According to a research by Credit Suisse, India needs about 1.7 billion Covid-19 vaccine doses to vaccinate majority of its adult population. It targets to administer 400-500 million doses by July 2021.

The key vaccines India is banking on are from Oxford/AstraZeneca, Novavax, and J&J as the temperature range of these vaccines is about 2-8-degree Celsius (vs -20-degree Celsius for Moderna and -70-degree Celsius for Pfizer).

The bottleneck is cold storage infrastructure (especially refrigerated vans) and by using a part of the capacity of current immunisation programme (600 million doses) and the cold chain infrastructure of the private sector (250-300 million doses), potential vaccinations can reach 550-600 million doses annually.  

Skilled manpower required to administer 550-600 million doses is less than 1 lakh, the report said, according to the news agency IANS.

Here are some key research findings:

Source: Credit Suisse(Graphics: Aroop Mishra/FIT)
Source: Credit Suisse(Graphics: Aroop Mishra/FIT)
Source: Credit Suisse(Graphics: Aroop Mishra/FIT)
Source: Credit Suisse(Graphics: Aroop Mishra/FIT)
Source: Credit Suisse(Graphics: Aroop Mishra/FIT)

(With inputs from IANS)

(At The Quint, we question everything. Play an active role in shaping our journalism by becoming a member today.)

Become a Member to unlock
  • Access to all paywalled content on site
  • Ad-free experience across The Quint
  • Early previews of our Special Projects
Continue

Published: 12 Nov 2020,06:03 PM IST

ADVERTISEMENT
SCROLL FOR NEXT